Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Dechra (DPH)

Price 3,824.00p on 30-11-2023 at 17:52:01
Change 0.00p 0%
Buy 3,826.00p
Sell 3,824.00p
Buy / Sell DPH Shares
Last Trade: Unknown 217.00 at 3,823.618p
Day's Volume: 1,199,540
Last Close: 3,824.00p
Open: 3,828.00p
ISIN: GB0009633180
Day's Range 3,818.00p - 3,828.00p
52wk Range: 2,474.00p - 3,882.00p
Market Capitalisation: £4,355m
VWAP: 3,825.0825p
Shares in Issue: 114m

Recent Trades History Dechra (DPH)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 217 3,823.618p Ordinary
Currency Conversion
OTC Trade
17:51:54 - 30-Nov-23
Unknown* 3,016 3,823.618p Ordinary
Currency Conversion
OTC Trade
17:51:01 - 30-Nov-23
Unknown* 6,856 3,824.00p Ordinary
Currency Conversion
17:44:04 - 30-Nov-23
Unknown* 35 3,824.00p Ordinary
Currency Conversion
17:44:03 - 30-Nov-23
Unknown* 649 3,824.00p Ordinary
Currency Conversion
17:44:03 - 30-Nov-23
Unknown* 95 3,824.00p Ordinary
Currency Conversion
17:44:03 - 30-Nov-23
Unknown* 2,301 3,826.191p Ordinary
Currency Conversion
OTC Trade
17:38:25 - 30-Nov-23
Unknown* 2,433 3,824.00p Ordinary
Currency Conversion
17:37:08 - 30-Nov-23
Unknown* 124 3,824.00p Ordinary
Currency Conversion
17:37:08 - 30-Nov-23
Unknown* 289 3,824.00p Ordinary
Currency Conversion
17:37:08 - 30-Nov-23

Share Price History for Dechra

Time period:
to
Date Open High Low Close Volume

Share News for Dechra

IN BRIEF: Hargreaves Lansdown picks Dechra chair Alison Platt as chair

29th Nov 2023 09:19

Hargreaves Lansdown PLC - Bristol, England-based wealth management platform - Hires Alison Platt, the current chair of Dechra Pharmaceuticals PLC, to be next its non-executive chair. Platt replaces Deanna Oppenheimer, who will leave the Hargreaves board at its annual general meeting on Friday next week, having been chair for six years. Platt will join the Hargreaves board in early 2024. Until regulatory approval for Platt, Senior Independent Director Penny James will be interim chair. Dechra, a veterinary drugmaker, has agreed to be taken over by EQT, which is a Swedish private equity firm, and Luxinva SA, which is controlled by the sovereign wealth fund of the United Arab Emirates. The GBP4.5 billion deal is expected to be completed by early 2024. Platt also is a non-executive director of grocer Tesco PLC and chair of general insurer Ageas (UK) Ltd. Previously, she led estate agent Countrywide as chief executive officer from 2014 to 2018. Read More

LONDON MARKET OPEN: FTSE 100 falls; Halfords, Xaar plunge

29th Nov 2023 08:26

(Alliance News) - Stock prices in London opened mixed on Wednesday, as large caps fell on account of a stronger pound, though the domestically-focused midcap index rose. Read More

LONDON BRIEFING: Hargreaves Lansdown says Dechra's Platt to be chair

29th Nov 2023 07:39

(Alliance News) - Stocks in London are expected to open lower on Wednesday, as investors consider the latest dovish remarks from the US Federal Reserve. Read More

Dechra Pharmaceuticals director steps down after 12 years

27th Nov 2023 08:44

(Alliance News) - Dechra Pharmaceuticals PLC on Monday said Director Tony Griffin has stepped down after 12 years in the role, effective immediately. Read More

TOP NEWS: Dechra Pharma swings to loss ahead of takeover by EQT

12th Oct 2023 09:03

(Alliance News) - Dechra Pharmaceuticals PLC on Thursday said it swung to an annual loss as it lamented high inflation and cost of sales, despite growth in all pharmaceutical product categories. Read More

FTSE 100 Latest
Value7,453.75
Change30.29

Login to your account

Forgot Password?

Not Registered